PubRank

T Sharp

Author PubWeight™ 131.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A review of central 5-HT receptors and their function. Neuropharmacology 1999 6.13
2 Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J Neurosci 2004 2.35
3 Cross infection control measures and the treatment of patients at risk of Creutzfeldt Jakob disease in UK general dental practice. Br Dent J 2001 2.08
4 The role of breakfast in the treatment of obesity: a randomized clinical trial. Am J Clin Nutr 1992 1.83
5 Neurochemical and anatomical identification of fast- and slow-firing neurones in the rat dorsal raphe nucleus using juxtacellular labelling methods in vivo. Neuroscience 2003 1.61
6 In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine. J Neurochem 1983 1.60
7 Differential involvement of serotonin and dopamine systems in cost-benefit decisions about delay or effort. Psychopharmacology (Berl) 2004 1.58
8 An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat. Neuroscience 1998 1.47
9 The effect of prolonged pneumoperitoneum on renal function in an animal model. J Am Coll Surg 1996 1.41
10 A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res 1987 1.36
11 Evidence for a role of GABA interneurones in the cortical modulation of midbrain 5-hydroxytryptamine neurones. Neuroscience 2001 1.30
12 Confounding effects of anesthesia on functional activation in rodent brain: a study of halothane and alpha-chloralose anesthesia. Neuroimage 2005 1.30
13 Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br J Pharmacol 1995 1.26
14 In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur J Pharmacol 1988 1.14
15 Electrophysiological evidence for convergence of inputs from the medial prefrontal cortex and lateral habenula on single neurons in the dorsal raphe nucleus. Eur J Neurosci 2003 1.13
16 Widespread distribution of binding sites for the novel Ca2+-mobilizing messenger, nicotinic acid adenine dinucleotide phosphate, in the brain. J Biol Chem 2000 1.12
17 Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release. Psychopharmacology (Berl) 1999 1.12
18 Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis. J Neurochem 1997 1.11
19 Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat. Br J Pharmacol 1999 1.10
20 Neurochemical and electrophysiological studies on the functional significance of burst firing in serotonergic neurons. Neuroscience 2000 1.06
21 Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry. Neuroscience 2000 1.04
22 Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness. Br J Psychiatry 2001 1.04
23 Evidence for a repetitive (burst) firing pattern in a sub-population of 5-hydroxytryptamine neurons in the dorsal and median raphe nuclei of the rat. Neuroscience 1995 1.03
24 Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology 1995 1.02
25 In vivo evidence that 5-HT(2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanism. Br J Pharmacol 2006 1.02
26 Power of exclusion for parentage verification and probability of match for identity in American Kennel Club breeds using 17 canine microsatellite markers. Anim Genet 2004 1.01
27 Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine. Naunyn Schmiedebergs Arch Pharmacol 1995 1.01
28 Biological mesh reconstruction of perineal wounds following enhanced abdominoperineal excision of rectum (APER). Int J Colorectal Dis 2011 1.01
29 Nutrient balance in humans: effects of diet composition. Am J Clin Nutr 1991 0.98
30 Changes in blood lipids during six days of overfeeding with medium or long chain triglycerides. J Lipid Res 1990 0.98
31 Comparative studies of Cu-64-ATSM and C-11-acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in rats. Nucl Med Biol 1999 0.98
32 Welfare aspects of vertebrate pest control and culling: ranking control techniques for humaneness. Rev Sci Tech 2014 0.96
33 Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. Life Sci 1991 0.96
34 A study of attachment loss patterns in survivor teeth at 18 months, 36 months and 5 years in community-dwelling older adults. J Periodontal Res 1997 0.95
35 Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function. Neuropharmacology 2007 0.93
36 Evaluation of an alternating-calorie diet with and without exercise in the treatment of obesity. Am J Clin Nutr 1989 0.92
37 Evidence that central 5-HT2A and 5-HT2B/C receptors regulate 5-HT cell firing in the dorsal raphe nucleus of the anaesthetised rat. Br J Pharmacol 2003 0.91
38 A comparison of the locomotor effects induced by centrally injected TRH and TRH analogues. Regul Pept 1984 0.91
39 Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors. Br J Pharmacol 1990 0.91
40 Comparison of the effects of alpha-methyl-p-tyrosine and a tyrosine-free amino acid load on extracellular noradrenaline in the rat hippocampus in vivo. J Psychopharmacol 1999 0.91
41 Further pharmacological characterization of 5-HT(2C) receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo. Br J Pharmacol 2009 0.91
42 An in vivo study of dopamine release and metabolism in rat brain regions using intracerebral dialysis. J Neurochem 1986 0.90
43 Olanzapine activates the rat locus coeruleus: in vivo electrophysiology and c-Fos immunoreactivity. Biol Psychiatry 2001 0.89
44 Fat distribution is altered in HIV-infected men without clinical evidence of the HIV lipodystrophy syndrome. HIV Med 2003 0.89
45 Effect of naloxone-precipitated morphine withdrawal on noradrenaline release in rat hippocampus in vivo. Eur J Pharmacol 1992 0.89
46 Changes in monoamine metabolites measured by simultaneous in vivo differential pulse voltammetry and intracerebral dialysis. Neuroscience 1984 0.89
47 p-Chloroamphetamine releases both serotonin and dopamine into rat brain dialysates in vivo. Neurosci Lett 1986 0.89
48 In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysis. Brain Res 1986 0.89
49 Effect of 5-hydroxy-L-tryptophan on the release of 5-HT in rat hypothalamus in vivo as measured by microdialysis. Neuropharmacology 1992 0.89
50 p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo. Psychopharmacology (Berl) 1994 0.88
51 Modulation of hippocampal dopamine metabolism and hippocampal-dependent cognitive function by catechol-O-methyltransferase inhibition. J Psychopharmacol 2012 0.87
52 Antidepressant drug treatment induces Arc gene expression in the rat brain. Neuroscience 2003 0.87
53 Analeptic effects of centrally injected TRH and analogues of TRH in the pentobarbitone-anaesthetized rat. Neuropharmacology 1984 0.87
54 Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine. Eur J Pharmacol 2000 0.86
55 Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo. Br J Pharmacol 1998 0.86
56 Affinity of (+/-)-pindolol, (-)-penbutolol, and (-)-tertatolol for pre- and postsynaptic serotonin 5-HT(1A) receptors in human and rat brain. J Neurochem 2000 0.86
57 A 5-year study of attachment loss and tooth loss in community-dwelling older adults. J Periodontal Res 1997 0.86
58 Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study. Br J Pharmacol 1999 0.86
59 Thermogenesis in humans during overfeeding with medium-chain triglycerides. Metabolism 1989 0.86
60 Spike-timing relationship of neurochemically-identified dorsal raphe neurons during cortical slow oscillations. Neuroscience 2011 0.85
61 Glutamate receptor activation is involved in 5-HT2 agonist-induced Arc gene expression in the rat cortex. Neuropharmacology 2004 0.85
62 Gene expression array profile of human osteosarcoma. Br J Cancer 2003 0.85
63 Differential pulse voltammetry in vivo--evidence that uric acid contributes to the indole oxidation peak. Neurosci Lett 1983 0.85
64 Muscle hypertrophy with large-scale weight loss and resistance training. Am J Clin Nutr 1993 0.85
65 Influence of 5-HT1A receptors on central noradrenergic activity: microdialysis studies using (+/-)-MDL 73005EF and its enantiomers. Neuropharmacology 1999 0.85
66 Attenuation of some subjective effects of amphetamine following tyrosine depletion. J Psychopharmacol 1999 0.84
67 Intracellular recordings from burst-firing presumed serotonergic neurones in the rat dorsal raphe nucleus in vivo. Brain Res 1996 0.84
68 Measurement of GABA in rat brain microdialysates using o-phthaldialdehyde-sulphite derivatization and high-performance liquid chromatography with electrochemical detection. J Chromatogr 1994 0.83
69 Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo. J Pharmacol Exp Ther 1996 0.83
70 Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo. Br J Pharmacol 1992 0.83
71 In vitro evidence that 5-hydroxytryptamine increases efflux of glial glutamate via 5-HT(2A) receptor activation. J Neurosci Res 2002 0.83
72 GABA and mood disorders. Psychol Med 2003 0.83
73 Evidence that increased 5-HT release evokes region-specific effects on blood-oxygenation level-dependent functional magnetic resonance imaging responses in the rat brain. Neuroscience 2009 0.83
74 beta-blocker binding to human 5-HT(1A) receptors in vivo and in vitro: implications for antidepressant therapy. Neuropsychopharmacology 2000 0.83
75 GluN1 hypomorph mice exhibit wide-ranging behavioral alterations. Genes Brain Behav 2012 0.83
76 Mixed agonist/antagonist properties of NAN-190 at 5-HT1A receptors: behavioural and in vivo brain microdialysis studies. Life Sci 1990 0.83
77 In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol. J Pharmacol Exp Ther 1993 0.82
78 Clonidine but not nifedipine prevents the release of noradrenaline during naloxone-precipitated opiate withdrawal: an in vivo microdialysis study in the rat. Psychopharmacology (Berl) 1992 0.82
79 Nicotine inhibits firing activity of dorsal raphe 5-HT neurones in vivo. Naunyn Schmiedebergs Arch Pharmacol 2000 0.82
80 Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis. Eur J Pharmacol 1984 0.82
81 Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat. Psychopharmacology (Berl) 1998 0.82
82 Mice overexpressing the 5-hydroxytryptamine transporter show no alterations in feeding behaviour and increased non-feeding responses to fenfluramine. Psychopharmacology (Berl) 2008 0.82
83 Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: a brain dialysis study. Eur J Pharmacol 1986 0.82
84 Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on 5-HT cell firing and release: comparison between dorsal and median raphe 5-HT systems. Neuropharmacology 1998 0.82
85 Pindolol occupancy of 5-HT(1A) receptors measured in vivo using small animal positron emission tomography with carbon-11 labeled WAY 100635. Synapse 2000 0.82
86 Different tonic regulation of neuronal activity in the rat dorsal raphe and medial prefrontal cortex via 5-HT(1A) receptors. Neurosci Lett 2001 0.81
87 Acceptance of home and clinic-based cystic fibrosis carrier education and testing by first, second, and third degree relatives of cystic fibrosis patients. Am J Med Genet 1997 0.81
88 8-OH-DPAT-induced release of hippocampal noradrenaline in vivo: evidence for a role of both 5-HT1A and dopamine D1 receptors. Eur J Pharmacol 1996 0.81
89 HPLC-EC analysis of catechols and indoles in rat brain dialysates. Life Sci 1987 0.81
90 Effect of different 5-HT1A receptor antagonists in combination with paroxetine on expression of the immediate-early gene Arc in rat brain. Neuropharmacology 2003 0.81
91 Repeated ECS differentially affects rat brain 5-HT1A and 5-HT2A receptor expression. Neuroreport 1995 0.81
92 Inhibition of 5-HT cell firing in the DRN by non-selective 5-HT reuptake inhibitors: studies on the role of 5-HT1A autoreceptors and noradrenergic mechanisms. Psychopharmacology (Berl) 1997 0.81
93 Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis. Exp Brain Res 1986 0.81
94 Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: microdialysis studies in the awake and anaesthetized rat. Neuropharmacology 1994 0.81
95 A 5-hydroxytryptamine lesion markedly reduces the incidence of burst-firing dorsal raphe neurones in the rat. Neurosci Lett 1996 0.80
96 Expression of 5-HT receptors and the 5-HT transporter in rat brain after electroconvulsive shock. Neurosci Lett 1999 0.80
97 Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo. Naunyn Schmiedebergs Arch Pharmacol 1986 0.80
98 Burst-firing activity of presumed 5-HT neurones of the rat dorsal raphe nucleus: electrophysiological analysis by antidromic stimulation. Brain Res 1996 0.80
99 The practical application of the Portion Diffusion Sampler for the measurement of time weighted average exposure to volatile organic substances in air. Ann Occup Hyg 1977 0.80
100 Studies on the role of 5-HT1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release--I. BMY7378 and prazosin. Neuropharmacology 1995 0.80
101 Shared changes in gene expression in frontal cortex of four genetically modified mouse models of depression. Eur Neuropsychopharmacol 2010 0.80
102 Risk factors for predicting surgical salvage of sternal wound-healing complications. Ann Plast Surg 1999 0.79
103 Electrochemical monitoring of 5-hydroxytryptamine release in vitro and related in vivo measurements of indoleamines. J Physiol (Paris) 1981 0.79
104 Infusional 5-fluorouracil and X-ray therapy for non-resectable esophageal cancer. Cancer 1980 0.79
105 A manually-operated brain tissue slicer suitable for neurotransmitter release studies. J Neurosci Methods 1983 0.79
106 Effect of sulpiride on amphetamine-induced behaviour in relation to changes in striatal dopamine release in vivo. Eur J Pharmacol 1986 0.79
107 In vivo monoamine release during naloxone-precipitated morphine withdrawal. Neuroreport 1993 0.79
108 Evaluation of a two-site immunoradiometric assay for measuring noncomplexed (free) prostate-specific antigen. Clin Chem 1996 0.79
109 Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis. Neuroscience 1987 0.79
110 Evidence that the large neutral amino acid L-valine decreases electrically-evoked release of 5-HT in rat hippocampus in vivo. Psychopharmacology (Berl) 1992 0.78
111 Critical issues in the antisense inhibition of brain gene expression in vivo: experiences targetting the 5-HT1A receptor. Neurochem Int 1997 0.78
112 Increase of 5-HT7 (serotonin-7) and 5-HT1A (serotonin-1A) receptor mRNA expression in rat hippocampus after adrenalectomy. Psychopharmacology (Berl) 1997 0.78
113 An investigation of the origin of extracellular GABA in rat nucleus accumbens measured in vivo by microdialysis. J Neural Transm Gen Sect 1994 0.78
114 Multiple laboratory comparison of the doubly labeled water technique. Obes Res 1995 0.78
115 Electroconvulsive shock increases dopamine D1 and D2 receptor mRNA in the nucleus accumbens of the rat. Psychopharmacology (Berl) 1995 0.78
116 Fos expression in the brains of rats performing an attentional set-shifting task. Neuroscience 2010 0.78
117 Isolation of Haemophilus taxon D from pigs in Australia. Aust Vet J 1994 0.77
118 Repeated administration of fluoxetine, desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat. J Psychopharmacol 1998 0.77
119 Behavioural and neuroendocrine responses to D-fenfluramine in rats treated with neurotoxic amphetamines. J Psychopharmacol 1995 0.77
120 Thyrotrophin-releasing hormone analogues increase dopamine release from slices of rat brain. J Neurochem 1982 0.77
121 Release of cerebral 5-hydroxytryptamine evoked by electrical stimulation of the dorsal and median raphe nuclei: effect of a neurotoxic amphetamine. Neuroscience 1995 0.77
122 SERT and uncertainty: serotonin transporter expression influences information processing biases for ambiguous aversive cues in mice. Genes Brain Behav 2015 0.77
123 Tyrosine depletion attenuates the behavioural stimulant effects of amphetamine and cocaine in rats. Eur J Pharmacol 2001 0.77
124 High-frequency stimulation of the subthalamic nucleus inhibits the firing of juxtacellular labelled 5-HT-containing neurones. Neuroscience 2011 0.77
125 5-HT neurones--bursting with information? Trends Neurosci 1997 0.76
126 Evaluation of the effect of chronic antidepressant treatment on neurokinin-1 receptor expression in the rat brain. Neuropharmacology 2004 0.76
127 The putative 5-HT1A antagonist BMY 7378 blocks 8-OH-DPAT-induced changes in local cerebral glucose utilization in the conscious rat. Neuropharmacology 1992 0.76
128 Determination of dopamine and its metabolites in small volumes of rat brain dialysates using small-bore liquid chromatography with electrochemical detection. J Chromatogr 1986 0.76
129 Structural and functional analysis of raphe neurone implants into denervated rat spinal cord. Brain Res Bull 1989 0.76
130 Evidence that the enhancement of dopamine function by repeated electroconvulsive shock requires concomitant activation of D1-like and D2-like dopamine receptors. Psychopharmacology (Berl) 1997 0.76
131 Intracerebral dialysis coupled to a novel activity box--a method to monitor dopamine release during behaviour. Pharmacol Biochem Behav 1986 0.76
132 Functional MR imaging of the porcine kidney: physiologic changes of prolonged pneumoperitoneum. JSLS 1999 0.76
133 Effects of the 5-HT1A partial agonists gepirone, ipsapirone and buspirone on local cerebral glucose utilization in the conscious rat. Psychopharmacology (Berl) 1992 0.76
134 Threat of hepatitis E virus infection in Somalia during Operation Restore Hope. Clin Infect Dis 1994 0.76
135 A new plasmid-based microRNA inhibitor system that inhibits microRNA families in transgenic mice and cells: a potential new therapeutic reagent. Gene Ther 2016 0.75
136 Effect of 5-HT(1A) receptor ligands on Fos-like immunoreactivity in rat brain: evidence for activation of noradrenergic transmission. Synapse 1999 0.75
137 Inadvertent paravertebral block. Anaesthesia 1989 0.75
138 Promoting sexual health. BMJ 1992 0.75
139 GABA transmission in the ventral pallidum is not involved in the control of latent inhibition in the rat. Neuroscience 2003 0.75
140 Restoration of function to the denervated spinal cord after implantation of embryonic 5HT- and substance P-containing raphe neurones. Prog Brain Res 1990 0.75
141 Selective 5-HT1A and 5-HT2 receptor-mediated adrenocorticotropin release in the rat: effect of repeated antidepressant treatments. Eur J Pharmacol 1992 0.75
142 Health occupations education at the secondary level. Hosp Prog 1972 0.75
143 Effects of subchronic haloperidol and sulpiride on regional brain dopamine metabolism in the rat. Eur J Pharmacol 1986 0.75
144 Focus on support for those who care. Nurs Elder 1990 0.75
145 Respite care. What a relief. Geriatr Nurs Home Care 1988 0.75
146 Continuous thoracic paravertebral block. J Cardiothorac Anesth 1989 0.75
147 Questions of quality. Nurs Elder 1991 0.75
148 Endoscopic evaluation of slow-release potassium chloride preparations. Clin Pharmacol Ther 1985 0.75
149 Enhancement of dopamine-mediated behaviour by the NMDA antagonists MK-801 and CPP: similarities with repeated electroconvulsive shock. Psychopharmacology (Berl) 1997 0.75
150 The TRH analogue CG3509 increases in vivo catechol/ascorbate oxidation in the N. accumbens but not in the striatum of the rat. Neuropharmacology 1984 0.75
151 Pulmonary function and 81mKr scans in obstructive pulmonary disease. Int J Nucl Med Biol 1981 0.75
152 Needs of the carer. All in a day's work. Nurs Times 1991 0.75
153 Recall and recognition memory for remotely acquired information in dementia patients. J Genet Psychol 1990 0.75
154 cis-(+)-8-OH-1-CH3-DPAT, (+)ALK-3, a novel stereoselective pharmacological probe for characterizing 5-HT release-controlling 5-HT1A autoreceptors. An in vivo brain microdialysis study. Naunyn Schmiedebergs Arch Pharmacol 1990 0.75
155 Electroconvulsive shock increases tachykinin NK(1) receptors, but not the encoding mRNA, in rat cortex. Eur J Pharmacol 2001 0.75
156 Unpopular psychiatric patients. Nurs Times 1990 0.75
157 Establishment of a clinically correlated human pericardial fluid bank: evaluation of intrapericardial diagnostic potential. Clin Cardiol 1999 0.75
158 The effects of aerobic exercise on psychological adjustment: a randomized study of sedentary obese women attempting weight loss. Women Health 1992 0.75
159 Virus-like filamentous intranuclear inclusions in a giant-cell tumor, not associated with Paget's disease of bone. A case report. J Bone Joint Surg Am 1985 0.75
160 The effect of kainic acid on the release of GABA in rat neostriatum and substantia nigra. Neuroreport 1994 0.75
161 Listening to carers. Nurs Times 1992 0.75
162 Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3. Eur J Pharmacol 1989 0.75
163 Let relatives help elderly mentally ill. Nurs Times 1989 0.75
164 Rapid postmortem increase in extracellular dopamine in the rat brain as assessed by brain microdialysis. J Neurochem 1988 0.75
165 Highly resistant bacterial osteomyelitis in Somalia. East Afr Med J 1994 0.75
166 Differential pulse voltammetry: simultaneous in vivo measurement of ascorbic acid, catechols and 5-hydroxyindoles in the rat striatum. Brain Res 1984 0.75
167 Whose problem? Nurs Times 1991 0.75
168 Care of elderly people. Old and in the way. Nurs Stand 1991 0.75
169 The research component of graduate nursing programs: the acquisition of competence. NLN Publ 1987 0.75
170 Comparison of the effect of buspirone and 1-(2-pyrimidinyl)-piperazine on cerebral glucose utilization in the rat. Eur J Pharmacol 1993 0.75